The SPARC IBD is an ongoing large prospective cohort with longitudinal standardized collection of clinical data, biosamples, and PROs representing a unique resource aimed to drive discovery of clinical and molecular markers that will meet the needs of precision medicine in IBD.
No takes yet. Share an insight, caveat, or question.
Raffals et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: